Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Korea.
Perit Dial Int. 2013 Jul-Aug;33(4):382-90. doi: 10.3747/pdi.2011.00279. Epub 2013 Jan 2.
Several studies have reported benefits for human peritoneal mesothelial cell function of a neutral-pH dialysate low in glucose degradation products (GDPs). However, the effects of low-GDP solution on ultrafiltration (UF), transport of solutes, and control of body water remain elusive. We therefore investigated the effect of low-GDP solution on UF, solute transport, and control of body water.
Among 79 new continuous ambulatory peritoneal dialysis (CAPD) patients, 60 completed a 12-month protocol (28 in a lactate-based high-GDP solution group, 32 in a lactate-based low-GDP solution group). Clinical indices--including 24-hour UF volume (UFV), 24-hour urine volume (UV), residual renal function, and dialysis adequacy--were measured at months 1, 6, and 12. At months 1, 6, and 12, UFV, glucose absorption, 4-hour dialysate-to-plasma (D/P) creatinine, and 1-hour D/P Na(+) were assessed during a modified 4.25% peritoneal equilibration test (PET). Body composition by bioelectric impedance analysis was measured at months 1 and 12 in 26 CAPD patients.
Daily UFV was lower in the low-GDP group. Despite similar solute transport and aquaporin function, the low-GDP group also showed lower UFV and higher glucose absorption during the PET. Factors associated with UFV during the PET were lactate-based high-GDP solution and 1-hour D/P Na(+). No differences in volume status and obesity at month 12 were observed, and improvements in hypervolemia were equal in both groups.
Compared with the high-GDP group, the low-GDP group had a lower UFV during a PET and a lower daily UFV during the first year after peritoneal dialysis initiation. Although the low-GDP group had a lower daily UFV, no difficulties in controlling edema were encountered.
多项研究报告称,葡萄糖降解产物(GDP)含量低的中性 pH 值透析液有益于人腹膜间皮细胞功能。然而,低 GDP 溶液对超滤(UF)、溶质转运和体液控制的影响仍不清楚。因此,我们研究了低 GDP 溶液对 UF、溶质转运和体液控制的影响。
在 79 名新开始持续不卧床腹膜透析(CAPD)的患者中,有 60 名完成了 12 个月的方案(28 名在基于乳酸盐的高 GDP 溶液组,32 名在基于乳酸盐的低 GDP 溶液组)。在第 1、6 和 12 个月时,测量了 24 小时 UF 量(UFV)、24 小时尿量(UV)、残余肾功能和透析充分性等临床指标。在第 1、6 和 12 个月时,在改良的 4.25%腹膜平衡试验(PET)期间评估了 UFV、葡萄糖吸收、4 小时透析液与血浆(D/P)肌酐和 1 小时 D/P Na(+)。在 26 名 CAPD 患者中,在第 1 和 12 个月时通过生物电阻抗分析测量了身体成分。
低 GDP 组的每日 UFV 较低。尽管溶质转运和水通道蛋白功能相似,但低 GDP 组在 PET 期间也显示出较低的 UFV 和较高的葡萄糖吸收。PET 期间与 UFV 相关的因素是基于乳酸盐的高 GDP 溶液和 1 小时 D/P Na(+)。在第 12 个月时,未观察到容量状态和肥胖的差异,两组的高血容量改善程度相同。
与高 GDP 组相比,低 GDP 组在 PET 期间 UFV 较低,腹膜透析开始后第一年的每日 UFV 较低。尽管低 GDP 组的每日 UFV 较低,但并未出现控制水肿的困难。